Literature DB >> 32221599

Changes in Cigarettes per Day and Biomarkers of Exposure Among US Adult Smokers in the Population Assessment of Tobacco and Health Study Waves 1 and 2 (2013-2015).

Brian L Rostron1, Catherine G Corey1, Joanne T Chang1, Dana M van Bemmel1, Mollie E Miller1, Cindy M Chang1.   

Abstract

INTRODUCTION: Some studies have found some reduction in tobacco exposure and tobacco-related disease risk with decreased numbers of cigarettes smoked per day (CPD), but biomarker of exposure estimates by change in CPD are generally unavailable for the US population.
METHODS: We analyzed biomarker of exposure data by smoking status from over 1100 adult exclusive daily cigarette smokers in Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study who were either exclusive daily smokers or had quit tobacco use entirely at Wave 2. Wave 1 smoking categories consisted of "very light" (1-4 CPD), "light" (5-9 CPD), "moderate" (10-19 CPD), and "heavy" (20+ CPD), and Wave 2 categories were "quitters" (stopped smoking entirely), exclusive cigarette "reducers" (CPD decreased ≥ 50%), "maintainers" (CPD within 50%-150% of Wave 1 value), and "increasers" (CPD increased ≥ 50%).
RESULTS: Complete quitters had significantly lower levels of TNE-2, NNAL, NNN, 2-Fluorene, HPMA, CYMA, and MHB3 at Wave 2 for all Wave 1 CPD categories, and decreases were often large. Moderate "reducers" had lower levels of NNAL and 1-Hydroxypyrene at Wave 2, and heavy "reducers" had lower levels of NNAL, 2-Fluorene, and MHB3. Light "increasers" had higher levels of TNE-2, NNAL, 2-Fluorene, CYMA, and cadmium at Wave 2, and heavy "increasers" had higher levels of NNAL and HPMA.
CONCLUSIONS: Smoking "reducers" and "increasers" had changes in some biomarker of tobacco exposure levels, but reductions were much greater and more consistent for complete quitters. IMPLICATIONS: PATH longitudinal cohort study data show that some exclusive daily cigarette smokers increase or decrease CPD over time. These differences may result in moderate changes in the levels of some biomarkers such as NNAL. Even so, however, reductions in biomarker levels are much greater with complete smoking cessation. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco 2020.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32221599      PMCID: PMC7542633          DOI: 10.1093/ntr/ntaa038

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  25 in total

Review 1.  Reduced smoking: an introduction and review of the evidence.

Authors:  J R Hughes
Journal:  Addiction       Date:  2000-01       Impact factor: 6.526

2.  Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.

Authors:  M J Jarvis; M A Russell; N L Benowitz; C Feyerabend
Journal:  Am J Public Health       Date:  1988-06       Impact factor: 9.308

3.  Effect of smoking reduction on lung cancer risk.

Authors:  Nina S Godtfredsen; Eva Prescott; Merete Osler
Journal:  JAMA       Date:  2005-09-28       Impact factor: 56.272

4.  A multi-rule Shewhart chart for quality control in clinical chemistry.

Authors:  J O Westgard; P L Barry; M R Hunt; T Groth
Journal:  Clin Chem       Date:  1981-03       Impact factor: 8.327

5.  Tobacco harm reduction: conceptual structure and nomenclature for analysis and research.

Authors:  Saul Shiffman; Joe G Gitchell; Kenneth E Warner; John Slade; Jack E Henningfield; John M Pinney
Journal:  Nicotine Tob Res       Date:  2002       Impact factor: 4.244

Review 6.  Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke.

Authors:  J Fowles; E Dybing
Journal:  Tob Control       Date:  2003-12       Impact factor: 7.552

7.  Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study.

Authors:  N S Godtfredsen; M Osler; J Vestbo; I Andersen; E Prescott
Journal:  J Epidemiol Community Health       Date:  2003-06       Impact factor: 3.710

8.  21st-century hazards of smoking and benefits of cessation in the United States.

Authors:  Prabhat Jha; Chinthanie Ramasundarahettige; Victoria Landsman; Brian Rostron; Michael Thun; Robert N Anderson; Tim McAfee; Richard Peto
Journal:  N Engl J Med       Date:  2013-01-24       Impact factor: 91.245

9.  Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.

Authors:  Andrew Hyland; Bridget K Ambrose; Kevin P Conway; Nicolette Borek; Elizabeth Lambert; Charles Carusi; Kristie Taylor; Scott Crosse; Geoffrey T Fong; K Michael Cummings; David Abrams; John P Pierce; James Sargent; Karen Messer; Maansi Bansal-Travers; Ray Niaura; Donna Vallone; David Hammond; Nahla Hilmi; Jonathan Kwan; Andrea Piesse; Graham Kalton; Sharon Lohr; Nick Pharris-Ciurej; Victoria Castleman; Victoria R Green; Greta Tessman; Annette Kaufman; Charles Lawrence; Dana M van Bemmel; Heather L Kimmel; Ben Blount; Ling Yang; Barbara O'Brien; Cindy Tworek; Derek Alberding; Lynn C Hull; Yu-Ching Cheng; David Maklan; Cathy L Backinger; Wilson M Compton
Journal:  Tob Control       Date:  2016-08-08       Impact factor: 7.552

10.  Effect of smoking reduction and cessation on the plasma levels of the oxidative stress biomarker glutathione--Post-hoc analysis of data from a smoking cessation trial.

Authors:  Ute Mons; Joshua E Muscat; Jennifer Modesto; John P Richie; Hermann Brenner
Journal:  Free Radic Biol Med       Date:  2015-12-18       Impact factor: 7.376

View more
  4 in total

1.  Prenatal urinary metabolites of polycyclic aromatic hydrocarbons and toddler cognition, language, and behavior.

Authors:  Erin R Wallace; Yu Ni; Christine T Loftus; Alexis Sullivan; Erin Masterson; Adam A Szpiro; Drew B Day; Morgan Robinson; Kurunthachalam Kannan; Fran A Tylavsky; Sheela Sathyanarayana; Nicole R Bush; Kaja Z LeWinn; Catherine J Karr
Journal:  Environ Int       Date:  2021-12-11       Impact factor: 9.621

Review 2.  1,3-Butadiene: a ubiquitous environmental mutagen and its associations with diseases.

Authors:  Wan-Qi Chen; Xin-Yu Zhang
Journal:  Genes Environ       Date:  2022-01-10

3.  Changes in Biomarkers of Tobacco Exposure among Cigarette Smokers Transitioning to ENDS Use: The Population Assessment of Tobacco and Health Study, 2013-2015.

Authors:  Gabriella M Anic; Brian L Rostron; Hoda T Hammad; Dana M van Bemmel; Arseima Y Del Valle-Pinero; Carol H Christensen; Gladys Erives; Lisa M Faulcon; Benjamin C Blount; Yuesong Wang; Lanqing Wang; Deepak Bhandari; Antonia M Calafat; Heather L Kimmel; Colm D Everard; Wilson M Compton; Kathryn C Edwards; Maciej L Goniewicz; Binnian Wei; Andrew Hyland; Dorothy K Hatsukami; Stephen S Hecht; Raymond S Niaura; Nicolette Borek; Bridget K Ambrose; Cindy M Chang
Journal:  Int J Environ Res Public Health       Date:  2022-01-27       Impact factor: 3.390

4.  Understanding heterogeneity among individuals who smoke cigarettes and vape: assessment of biomarkers of exposure and potential harm among subpopulations from the PATH Wave 1 Data.

Authors:  Pavel N Lizhnyak; Brendan Noggle; Lai Wei; Jeffery Edmiston; Elizabeth Becker; Ryan A Black; Mohamadi Sarkar
Journal:  Harm Reduct J       Date:  2022-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.